Xeris Biopharma Holdings, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC XERS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,403,824

Value ($000)

11,020

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	11,020	0.0%	1,403,824	12/31/2025
2025 Q3	11/10/2025	11,775	0.0%	1,446,619	9/30/2025
2025 Q2	8/12/2025	2,650	0.0%	567,538	6/30/2025
2025 Q1	9/15/2025	2,327	0.0%	423,775	3/31/2025
2024 Q4	2/6/2025	1,366	0.0%	402,872	12/31/2024
2024 Q3	11/12/2024	1,150	0.0%	403,361	9/30/2024
2024 Q2	8/12/2024	910	0.0%	404,582	6/30/2024
2024 Q1	5/9/2024	810	0.0%	366,293	3/31/2024
2023 Q4	2/6/2024	856	0.0%	364,382	12/31/2023
2023 Q3	11/8/2023	679	0.0%	365,013	9/30/2023
2023 Q2	8/10/2023	956	0.0%	365,013	6/30/2023
2023 Q1	5/12/2023	611	0.0%	374,991	3/31/2023
2022 Q4	2/13/2023	463	0.0%	348,237	12/31/2022
2022 Q3	11/14/2022	528	0.0%	337,827	9/30/2022
2022 Q2	8/15/2022	522	0.0%	338,390	6/30/2022
2022 Q1	5/13/2022	122	0.0%	47,467	3/31/2022
2021 Q4	2/11/2022	197	0.0%	67,010	12/31/2021